Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-07T11:32:27.276Z Has data issue: false hasContentIssue false
  • English
  • Français

Long-term follow-up of percutaneous secundum-type atrial septal defect closure using Amplatzer Septal Occluder since 1995: a single-centre study

Published online by Cambridge University Press:  11 September 2023

Peter Olejnik ,
Peter Tittel ,
Zuzana Venczelova ,
Marek Kardos ,
Jaroslav Tomko ,
Maria Bartova Open the ORCID record for Maria Bartova [Opens in a new window]  and
Jozef Masura
Peter Olejnik*
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia Department of Pediatric Cardiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
Peter Tittel
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia
Zuzana Venczelova
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia
Marek Kardos
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia
Jaroslav Tomko
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia Department of Pediatric Cardiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
Maria Bartova
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia Department of Pediatric Cardiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
Jozef Masura
Affiliation:
National Institute of Cardiovascular Diseases, Pediatric Cardiac Center, Bratislava, Slovakia Department of Pediatric Cardiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
*
Corresponding author: P. Olejnik; Email: petoolejnik@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction:

The goal of this single-centre study was to evaluate long-term results of percutaneous closure of secundum-type atrial septal defect using Amplatzer Septal Occluder with the follow-up to 25 years.

Methods:

A retrospective analysis of patients who underwent percutaneous closure of secundum-type atrial septal defect between September 1995 and October 2012 in our institution was performed. All procedures were performed after fulfilling strict indication criteria. More than 5 years follow-up was reached in 651/803 patients (81%) with median follow-up time of 12 (5–25) years.

Results:

The mean stretched defect diameter was 14,0 ± 5,2 mm. Early reintervention due to moderate or severe residual atrial septal defect had to be performed in 3/803 patients (0,03%). The incidence of long-term moderate or severe residual atrial septal defect was 0,0%. The complete closure rate at 10-year follow-up was 98,5%, as trivial residual shunts persisted in 8/508 patients (1,5%). A significant rate of the echocardiographic right ventricular end-diastolic diameter post-procedural normalisation (p < 0,05) was encountered. The rate of major complications was 0,5%. One device embolisation, one thrombus formation at the occluder surface, and one cardiac erosion in periprocedural or short post-procedural course were experienced. Only one late complication of infective endocarditis at the region of implanted occluder and the aortic valve was detected. The survival rate of all followed patients was 100%.

Conclusions:

Percutaneous closure of secundum-type atrial septal defect using Amplatzer Septal Occluder is a safe and effective procedure accounting for a very low incidence of major complications in the long-term follow-up.

Keywords

Atrial septal defectamplatzer Septal Occluderlong-term follow-up
Type
Original Article
Information
Cardiology in the Young , Volume 34 , Issue 3 , March 2024 , pp. 643 - 646
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Masura, J, Gavora, P, Formanek, A, Hijazi, ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997; 42: 388–393. DOI: 10.1002/(sici)1097-0304(199712)42:43.0.co;2-7.Google Scholar
Masura, J, Gavora, P, Podnar, T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 2005; 45: 505–507. DOI: 10.1016/j.jacc.2004.10.066.Google Scholar
Kampmann, C, Wiethoff, CM, Wenzel, A, etal, H. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central europe. Heart 2000; 83: 667–672. DOI: 10.1136/heart.83.6.667.Google Scholar
Turner, DR, Owada, CY, Sang, CJ Jr, Khan, M, Lim, DS. Closure of secundum atrial septal defects with the AMPLATZER septal occluder: a prospective, multicenter, post-approval study. Circ Cardiovasc Interv 2017; 10: e004212. DOI: 10.1161/CIRCINTERVENTIONS.Google Scholar
Bialkowski, J, Kusa, J, Szkutnik, M, et al. Cierre percutáneo de la comunicación interauricular. Resultados a corto y mediano plazo [Percutaneous catheter closure of atrial septal defect. Short-term and mid-term results]. Rev Esp Cardiol 2003; 56: 383–388. DOI: 10.1016/s0300-8932(03)76882-1.Google Scholar
Jalal, Z, Hascoet, S, Baruteau, AE, et al. Long-term complications after transcatheter atrial septal defect closure: a review of the medical literature. Can J Cardiol 2016; 32: 1315.e11–1315.e18. DOI: 10.1016/j.cjca.2016.02.068.Google Scholar
Amin, Z, Hijazi, ZM, Bass, JL, et al. Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496–502. DOI: 10.1002/ccd.20211.Google Scholar
Chessa, M, Carminati, M, Butera, G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39: 1061–1065. DOI: 10.1016/s0735-1097(02)01711-4.Google Scholar
Levi, DS, Moore, JW. Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 2004; 61: 543–547. DOI: 10.1002/ccd.20011.Google Scholar
Dong-Jun, K, Chi Young, S, Seng Chan, Y, Seung-Hyun, L, Geu-Ru, H. Late bacterial endocarditis and abscess formation after implantation of an Amplatzer septal occluder device. Circulation 2015; 131: e536–e538.Google Scholar
Toporcer, T, Kolesár, A, Ledecký, M, Sabol, F. Late infective endocarditis of an Amplatzer atrial septal device twelve years after implantation. Cor Vasa 2018; 60: 174–178. DOI: 10.1016/j.crvasa.2017.01.006.Google Scholar
Krumsdorf, U, Ostermayer, S, Billinger, K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004; 43: 302–309.Google Scholar
Hikmet, Y, Ugur, C, Ergun Baris, K, Kudret, A. Thrombus formation during percutaneous closure of an atrial septal defect with an Amplatzer septal occluder. Tex Heart Inst J 2011; 38: 427–430.Google Scholar
Giraldo-Gonzalez, GC, Olaya, P, Domınguez, A, Sanchez, J, Vesga, CE. Very late Amplatzer device thrombosis and stroke. CASE 2020; 4: 25–27.Google Scholar
Hill, SL, Berul, CI, Patel, HT, et al. Abnormalities associated with transcatheter closure of atrial septal defects using the amplatzer® septal occluder. J Interv Card 2000; 4: 469–474. DOI: 10.1023/A:1009852312907.Google Scholar